Stagezero Life Sciences Ltd (SZLSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 500 | 390 | 522 | 0 | 746 |
| Cost of Goods | 569 | 382 | 221 | N/A | 577 |
| Gross Profit | -70 | 8 | 302 | N/A | 168 |
| Operating Expenses | 852 | 1,085 | 818 | 0 | 1,506 |
| Operating Income | -352 | -695 | -296 | N/A | -761 |
| Interest Expense | 47 | 53 | 41 | 0 | 27 |
| Other Income | 0 | 99 | -50 | 0 | -34 |
| Pre-tax Income | -399 | -650 | -386 | 0 | -822 |
| Net Income Continuous | -399 | -650 | -386 | N/A | -822 |
| Net Income | $-399 | $-650 | $-386 | $N/A | $-822 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.00 | N/A | -0.01 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | 0.00 | N/A | -0.01 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | N/A | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | 0.00 | N/A | -0.01 |
| EPS Diluted Before Non-Recurring Items | 0.00 | 0.00 | 0.00 | N/A | -0.01 |
| EBITDA(a) | $-369 | $-652 | $-277 | $N/A | $-723 |